New Business at Future Health 2018

DATE: 16.03.2018

A good two days at the Future Health 2018 congress, at London’s Olympia exhibition centre. Positive discussions were held with a number of new companies. One such business is Opus Innovations, who have the global rights to the Tickleflex insulin injection aid, for whom we will be carrying out market testing in South East Asia during the upcoming Asia Health exhibition in Singapore. This is a really great product, and just one of a number of innovations from Opus which we will be working on in the coming months.